• Filing Date: 2020-08-04
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Intangible Asset (Narrative) (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2014
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]            
Amortization of intangible assets     $ 967,000 $ 962,000    
Net intangible assets $ 13,816,000   13,816,000     $ 14,783,000
Impairment     0      
License            
Finite-Lived Intangible Assets [Line Items]            
Gross intangible assets 25,000,000   $ 25,000,000      
Useful life (in years)     13 years      
Amortization of intangible assets 484,000 $ 484,000        
Net intangible assets $ 13,816,000 $ 14,783,000 $ 13,816,000 $ 14,783,000    
pSivida            
Finite-Lived Intangible Assets [Line Items]            
Milestone payment after the first product approved by the FDA         $ 25,000,000